Ecovyst closes Calabrian deal, lifts 2026 sales outlook to $1.06B
What's the deal? EcovystDealroom has a profile for this one. Try Dealroom → completed its acquisition of CalabrianDealroom has a profile for this one. Try Dealroom →, a sulphur dioxide and derivatives business, from INEOS EnterprisesDealroom has a profile for this one. Try Dealroom → on June 30, 2026. The purchase was financed in part by a $100 million term loan increase.
What's the endgame? The deal expands Ecovyst's footprint in sulphur-based chemistry, adding Calabrian's sulphur dioxide and derivatives operations to its portfolio. Management expects the business to contribute in the second half of the year.
Why now? The acquisition landed as Ecovyst posted strong second-quarter results. Sales rose 42% to $250 million, up from $176.1 million a year earlier, driven by higher volumes and pricing — including about $55 million in sulphur cost pass-through.
By the numbers: Net income reached $10.7 million, a 4.3% margin, while adjusted net income was $23.4 million. Adjusted EBITDA rose 27% to $53.1 million.
Reflecting first-half performance and Calabrian's expected contribution, Ecovyst raised its 2026 sales guidance to $1.02–1.06 billion. Capital expenditures are now expected at $85–95 million.
The balance sheet: As of June 30, 2026, Ecovyst held $87.8 million in cash and total gross debt of $497.1 million, with total available liquidity of $176.3 million.
The signal: The Calabrian purchase deepens Ecovyst's exposure to sulphur chemistry at a time when a global sulphur squeeze is pressuring producers across the sector. For INEOS, the sale trims a non-core asset; for Ecovyst, it is a bet that added scale will offset rising input costs.
Read more: bcinsight.crugroup.com
Image credit: Nick Bramhall
